These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 24699889)

  • 1. Genistein increases glycosaminoglycan levels in mucopolysaccharidosis type I cell models.
    Kingma SD; Wagemans T; IJlst L; Wijburg FA; van Vlies N
    J Inherit Metab Dis; 2014 Sep; 37(5):813-21. PubMed ID: 24699889
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cyclodextrin encapsulation of daidzein and genistein by grinding: implication on the glycosaminoglycan accumulation in mucopolysaccharidosis type II and III fibroblasts.
    Fumić B; Jablan J; Cinčić D; Zovko Končić M; Jug M
    J Microencapsul; 2018 Jan; 35(1):1-12. PubMed ID: 29168930
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effects of flavonoids on glycosaminoglycan synthesis: implications for substrate reduction therapy in Sanfilippo disease and other mucopolysaccharidoses.
    Kloska A; Jakóbkiewicz-Banecka J; Narajczyk M; Banecka-Majkutewicz Z; Węgrzyn G
    Metab Brain Dis; 2011 Mar; 26(1):1-8. PubMed ID: 21305347
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Altered interaction and distribution of glycosaminoglycans and growth factors in mucopolysaccharidosis type I bone disease.
    Kingma SDK; Wagemans T; IJlst L; Bronckers ALJJ; van Kuppevelt TH; Everts V; Wijburg FA; van Vlies N
    Bone; 2016 Jul; 88():92-100. PubMed ID: 27105565
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Genistein-mediated inhibition of glycosaminoglycan synthesis, which corrects storage in cells of patients suffering from mucopolysaccharidoses, acts by influencing an epidermal growth factor-dependent pathway.
    Jakóbkiewicz-Banecka J; Piotrowska E; Narajczyk M; Barańska S; Wegrzyn G
    J Biomed Sci; 2009 Mar; 16(1):26. PubMed ID: 19272193
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cell cycle is disturbed in mucopolysaccharidosis type II fibroblasts, and can be improved by genistein.
    Moskot M; Gabig-Cimińska M; Jakóbkiewicz-Banecka J; Węsierska M; Bocheńska K; Węgrzyn G
    Gene; 2016 Jul; 585(1):100-103. PubMed ID: 27016302
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Adverse Effects of Genistein in a Mucopolysaccharidosis Type I Mouse Model.
    Kingma SD; Wagemans T; IJlst L; Seppen J; Gijbels MJ; Wijburg FA; van Vlies N
    JIMD Rep; 2015; 23():77-83. PubMed ID: 25854773
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Murine Fibroblasts and Primary Hepatocytes as Tools When Studying the Efficacy of Potential Therapies for Mucopolysaccharidosis Type I.
    Węsierska M; Nowicka W; Kloska A; Jakóbkiewicz-Banecka J; Malinowska M
    Int J Mol Sci; 2022 Dec; 24(1):. PubMed ID: 36613977
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibitors of dermatan sulfate epimerase 1 decreased accumulation of glycosaminoglycans in mucopolysaccharidosis type I fibroblasts.
    Maccarana M; Li B; Li H; Fang J; Yu M; Li JP
    Glycobiology; 2024 Apr; 34(6):. PubMed ID: 38760939
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Storage correction in cells of patients suffering from mucopolysaccharidoses types IIIA and VII after treatment with genistein and other isoflavones.
    Arfi A; Richard M; Gandolphe C; Scherman D
    J Inherit Metab Dis; 2010 Feb; 33(1):61-7. PubMed ID: 20084460
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Synthetic genistein derivatives as modulators of glycosaminoglycan storage.
    Kloska A; Narajczyk M; Jakóbkiewicz-Banecka J; Grynkiewicz G; Szeja W; Gabig-Cimińska M; Węgrzyn G
    J Transl Med; 2012 Jul; 10():153. PubMed ID: 22846663
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of iduronic acid biosynthesis by ebselen reduces glycosaminoglycan accumulation in mucopolysaccharidosis type I fibroblasts.
    Maccarana M; Tykesson E; Pera EM; Gouignard N; Fang J; Malmström A; Ghiselli G; Li JP
    Glycobiology; 2021 Nov; 31(10):1319-1329. PubMed ID: 34192316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intra-articular enzyme replacement therapy with rhIDUA is safe, well-tolerated, and reduces articular GAG storage in the canine model of mucopolysaccharidosis type I.
    Wang RY; Aminian A; McEntee MF; Kan SH; Simonaro CM; Lamanna WC; Lawrence R; Ellinwood NM; Guerra C; Le SQ; Dickson PI; Esko JD
    Mol Genet Metab; 2014 Aug; 112(4):286-93. PubMed ID: 24951454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Glycosaminoglycan-mediated loss of cathepsin K collagenolytic activity in MPS I contributes to osteoclast and growth plate abnormalities.
    Wilson S; Hashamiyan S; Clarke L; Saftig P; Mort J; Dejica VM; Brömme D
    Am J Pathol; 2009 Nov; 175(5):2053-62. PubMed ID: 19834056
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genistein reduces lysosomal storage in peripheral tissues of mucopolysaccharide IIIB mice.
    Malinowska M; Wilkinson FL; Bennett W; Langford-Smith KJ; O'Leary HA; Jakobkiewicz-Banecka J; Wynn R; Wraith JE; Wegrzyn G; Bigger BW
    Mol Genet Metab; 2009 Nov; 98(3):235-42. PubMed ID: 19632871
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence that glycosaminoglycan storage and collagen deposition in the cauda epididymidis does not impair sperm viability in the Mucopolysaccharidosis type I mouse model.
    do Nascimento CC; Aguiar O; Viana GM; D Almeida V
    Reprod Fertil Dev; 2020 Feb; 32(3):304-312. PubMed ID: 31679559
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genistein reduces glycosaminoglycan levels in a mouse model of mucopolysaccharidosis type II.
    Friso A; Tomanin R; Salvalaio M; Scarpa M
    Br J Pharmacol; 2010 Mar; 159(5):1082-91. PubMed ID: 20136838
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Rhodamine B and 2-acetamido-1,3,6-tri-O-acetyl-4-deoxy-4-fluoro-D-glucopyranose (F-GlcNAc) inhibit chondroitin/dermatan and keratan sulphate synthesis by different mechanisms in bovine chondrocytes.
    Derrick-Roberts AL; Marais W; Byers S
    Mol Genet Metab; 2012 Jun; 106(2):214-20. PubMed ID: 22546219
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genistein-mediated inhibition of glycosaminoglycan synthesis as a basis for gene expression-targeted isoflavone therapy for mucopolysaccharidoses.
    Piotrowska E; Jakóbkiewicz-Banecka J; Barańska S; Tylki-Szymańska A; Czartoryska B; Wegrzyn A; Wegrzyn G
    Eur J Hum Genet; 2006 Jul; 14(7):846-52. PubMed ID: 16670689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of expression of genes involved in glycosaminoglycan metabolism and lysosome biogenesis by flavonoids.
    Moskot M; Jakóbkiewicz-Banecka J; Kloska A; Smolińska E; Mozolewski P; Malinowska M; Rychłowski M; Banecki B; Węgrzyn G; Gabig-Cimińska M
    Sci Rep; 2015 Mar; 5():9378. PubMed ID: 25797591
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.